IMEXHS Reports FY25 Results
Filed with ASX · · 5 pages · English
• Underlying EBITDA1 of $1.6m up vs $0.5m in the prior year and at the top end of guidance of $1.3m to $1.6m. Financial Highlights • FY25 revenue of $29.0m, up 10% vs pcp and up 6% on a constant currency basis2. • FY25 recurring revenue of $28.5m, up 11% on a like for like basis excluding the current year one-off of $0.47m (Q4) and the prior year one-off of $0.73m (H1). • FY25 Underlying EBITDA of
In the deck
Earlier from ImExHS
- Appendix 4E & Annual Report 2025
- 2025 Q4 Quarterly Activities Report & Appendix 4C
- 2025 Q3 Quarterly Activities Report & Appendix 4C
- IMEXHS signs new radiology services contract
- 1H FY25 Results Investor Presentation
Later from ImExHS
- IMEXHS FY25 Investor Presentation
- IMEXHS launches agentic AI platform for radiology
- FY26 Q1 Quarterly Activities Report and Appendix 4C
- AGM - Chairman and CEO Addresses and Presentation
- IMEXHS Wins Aquila Public Tender in Mexico
Follow ImExHS into a list and get an email when it puts out news.
Follow ImExHS